# Study in Elderly Patients With Early Breast Cancer (ICE)

> **NCT00196859** · PHASE3 · COMPLETED · sponsor: **GBG Forschungs GmbH** · enrollment: 1500 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Ibandronate, Capecitabine
- **DRUG:** Ibandronate

## Key facts

- **NCT ID:** NCT00196859
- **Lead sponsor:** GBG Forschungs GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2014-07-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00196859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00196859, "Study in Elderly Patients With Early Breast Cancer (ICE)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00196859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*